EDGAR Filing Documents for 0001104659-20-044338

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001104659-20-044338

Filing Date

2020-04-08

Accepted

2020-04-07 19:19:08

Documents

Group Members

D-BETA ONE BLOCKER EQ, LTD.D-BETA ONE EQ, LTD.D-BETA ONE GP, LLCD-BETA ONE GROWTH & OPPORTUNITY FUND OFFSHORE, LPDELTA BETA ADVISORS, LLCDELTA BETA ADVISORS, LPMATTHEW BECKMANYA GLOBAL INVESTMENTS II (U.S.), LPYAII GP, LPYORKVILLE ADVISORS GLOBAL II, LLCY

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G	tm2015307d1_sc13g.htm	SC 13G	228894
2	EXHIBIT 99.1	tm2015307d1_ex99-1.htm	EX-99.1	35921
	Complete submission text file	0001104659-20-044338.txt		267089

Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302

Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300

YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017

Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022

Q BioMed Inc. (Subject) CIK: 0001596062 (see all company filings)